🩸 VTE Prophylaxis Decision — Medical Inpatients (Padua Score)
Assess venous thromboembolism risk in medical inpatients with the Padua Prediction Score and get prophylaxis guidance. Instant, browser-side.
VTE Prophylaxis Decision — Medical Inpatients (Padua Score)
Active cancer
Previous VTE (excluding superficial vein thrombosis)
Reduced mobility (bed rest ≥ 3 days)
Known thrombophilia
Recent (≤ 1 month) trauma or surgery
Age ≥ 70 years
Heart and/or respiratory failure
Acute MI or ischaemic stroke
Acute infection and/or rheumatologic disorder
Obesity (BMI ≥ 30)
Ongoing hormonal treatment
When to use
Decide whether a medical inpatient needs pharmacological VTE prophylaxis.
How it works
Padua: active cancer 3, prior VTE 3, immobility 3, thrombophilia 3, recent trauma/surgery 2, age ≥ 70 / cardiorespiratory failure / MI-stroke / acute infection-rheumatic / obesity / hormonal therapy 1 each. ≥ 4 = high risk.
Key points
- Padua ≥ 4 = high risk → pharmacological prophylaxis (LMWH, low-dose UFH or fondaparinux) absent contraindication.
- Assess bleeding risk (e.g. IMPROVE bleeding score) before starting prophylaxis.
- Where anticoagulation is contraindicated, use mechanical prophylaxis.
- Padua < 4 = low risk → routine pharmacological prophylaxis not recommended; encourage early mobilisation.
References
Decision support for licensed clinicians only; not a substitute for clinical judgement, diagnosis or local protocols.